End Cash: The amount of cash held by the company for the given period.
Regencell Bioscience Holdings Limited (RGC) had End Cash of $2.96M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.11M |
|
$0.93M |
|
$1.02M |
|
$8.44M |
|
$0.19M |
|
-- |
|
-- |
|
$0.22M |
|
$8.22M |
|
$8.22M |
|
$8.22M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
$5.24M |
|
$0.10M |
|
$1.56M |
|
|
End Cash |
$2.96M |
$1.40M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|